Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PMGC Holdings Inc. - Common Stock (NQ:ELAB)

8.160 +0.720 (+9.68%)
Streaming Delayed Price Updated: 3:36 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about PMGC Holdings Inc. - Common Stock

< Previous 1 2 3 Next >
Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement with Institutional Investors Priced At-The Market Under Nasdaq Rules
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC
From PMGC Holdings Inc.
Via GlobeNewswire
Pacific Sun Packaging, a Subsidiary of PMGC Holdings, Announces Attendance at 2025 ITAD Summit to Showcase Custom Protective Packaging for Enterprise IT Hardware
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company
From PMGC Holdings Inc.
Via GlobeNewswire
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22
From PMGC Holdings Inc.
Via GlobeNewswire
RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company
Acquisition Target Currently Serves over 300 Commercial Clients, which Includes Data Centers, Technology Manufacturers, and IT Service Providers with Close to 15 Years of Operational History, 90%... 
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K
From PMGC Holdings Inc.
Via GlobeNewswire
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Announces Share Repurchases from Existing Shareholders
From PMGC Holdings Inc.
Via GlobeNewswire
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
From PMGC Holdings Inc.
Via GlobeNewswire
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group
From PMGC Holdings Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.